Niagen Bioscience, Inc.
NAGE· Nasdaq
NAGENiagen Bioscience, Inc.
Filed Aug 9, 2012 · 10-Q · 40 days after period end · 0001415889-12-001164
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $2.67M | $1.94M | $2.03M |
| Net Income | -$3.99M | -$1.84M | -$303.53K |
| EPS Diluted | -$0.04 | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Niagen Bioscience, Inc. · CIK 1386570 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 9, 2012 · 40 d after period end
